| 1. | | Recruiting | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
| 2. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer
Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome |
| 3. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ... |
| 4. | | Recruiting | 17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease
Conditions: Hippel-Lindau Disease; Kidney Cancer |
| 5. | | No longer recruiting | 3-AP and Cytarabine in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease |
| 6. | | Recruiting | 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia |
| 7. | | Recruiting | 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: acute leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; chronic leukemia; ... |
| 8. | | Completed | 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
Condition: Beta Thalassemia |
| 9. | | No longer recruiting | 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Conditions: Leukemia; Lymphoma; Multiple Myeloma |
| 10. | | Completed | 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ... |
| 11. | | Completed | 8-Day Safety, Tolerability, and Effects Study of Inhaled INS37217 and Placebo In Adult and Pediatric Cystic Fibrosis Patients
Condition: Cystic Fibrosis |
| 12. | | Completed | Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
Conditions: Aniridia; Eye Abnormality; Ocular Hypertension; Open Angle Glaucoma |
| 13. | | Recruiting | ABT-751 in Treating Young Patients With Refractory Solid Tumors
Condition: childhood cancer |
| 14. | | Completed | Achilles Tendon Lengthening in Patients with Diabetes to Prevent Foot Ulcers
Conditions: Diabetes Mellitus; Foot Ulcer; Peripheral Neuropathy |
| 15. | | Recruiting | Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; oral complications of cancer and cancer therapy; Pain |
| 16. | | Not yet recruiting | Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Recurrent Accelerated or Blast Phase Chronic Myelogenous Leukemia After Undergoing Allogeneic Stem Cell Transplantation
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ... |
| 17. | | Not yet recruiting | Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease; Non-Hodgkin's Lymphoma; ... |
| 18. | | Recruiting | Alemtuzumab, Total-Body Irradiation, and Fludarabine Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 19. | | No longer recruiting | Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia |
| 20. | | Recruiting | Allo Transplantation with Mylotarg, fludarabine and melphalan for AML, CML and MDS.
Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia |
| 21. | | No longer recruiting | Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
Conditions: Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; ... |
| 22. | | Completed | Alpha-Galactosidase A Replacement Therapy for Fabry Disease
Condition: Fabry Disease |
| 23. | | Recruiting | Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
Condition: Fabry Disease |
| 24. | | Completed | Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; Drug Toxicity |
| 25. | | No longer recruiting | Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Conditions: untreated adult acute myeloid leukemia; Drug Toxicity; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ... |
| 26. | | No longer recruiting | Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
Conditions: Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts in transformation; ... |
| 27. | | No longer recruiting | Amifostine in Treating Patients With Myelodysplastic Syndrome
Conditions: Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome |
| 28. | | No longer recruiting | Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
Conditions: Previously Treated Myelodysplastic Syndrome; de novo myelodysplastic syndrome; refractory anemia with excess blasts in transformation; ... |
| 29. | | No longer recruiting | Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors
Conditions: childhood soft tissue sarcoma; childhood liver cancer; adult soft tissue sarcoma; Bone Cancer; ovarian sarcoma; Testicular Cancer; Brain Tumor; ... |
| 30. | | No longer recruiting | Amifostine With or Without Epoetin alfa in Treating Patients With Myelodysplastic Syndrome
Conditions: Refractory Anemia; Previously Treated Myelodysplastic Syndrome; Anemia; secondary myelodysplastic syndrome; ... |
| 31. | | No longer recruiting | Aminopterin in Treating Patients With Refractory Leukemia
Conditions: recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphocytic leukemia; ... |
| 32. | | Recruiting | Anakinra to Treat Patients with Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations; Arthropathy, Neurogenic; Urticaria; Papilledema |
| 33. | | Recruiting | Analysis of the Nervous System in Patients with Fabry's Disease
Condition: Fabry's Disease |
| 34. | | Completed | Antecedents of Bronchopulmonary Dysplasia
Conditions: Lung Diseases; Bronchopulmonary Dysplasia |
| 35. | | Recruiting | Anti-Thymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia |
| 36. | | No longer recruiting | Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
Condition: HIV Infections |
| 37. | | Completed | Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
Conditions: adult non-Hodgkin's lymphoma; Myeloproliferative Disorders; adult Hodgkin's disease; childhood non-Hodgkin's lymphoma; plasma cell neoplasm; Leukemia; ... |
| 38. | | Recruiting | Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ... |
| 39. | | No longer recruiting | Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
Condition: Myelodysplastic Syndrome |
| 40. | | No longer recruiting | Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
Conditions: Refractory Anemia; refractory anemia with excess blasts; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes |
| 41. | | No longer recruiting | Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer
Conditions: AIDS-related peripheral/systemic lymphoma; HIV-associated Hodgkin's disease; recurrent adult acute lymphocytic leukemia; ... |
| 42. | | Recruiting | Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
Conditions: Anemia, Sickle Cell; Pneumonia |
| 43. | | Recruiting | Arimidex in McCune Albright Syndrome
Condition: McCune-Albright Syndrome |
| 44. | | Recruiting | Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; ... |
| 45. | | Completed | Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia
Conditions: untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ... |
| 46. | | Recruiting | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Condition: childhood cancer |
| 47. | | No longer recruiting | Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 48. | | No longer recruiting | Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia or With Chronic Myelogenous Leukemia
Conditions: Leukemia; Lymphoma; Multiple Myeloma |
| 49. | | No longer recruiting | Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia
Conditions: recurrent childhood acute myeloid leukemia; recurrent adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3); ... |
| 50. | | No longer recruiting | Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
Conditions: Leukemia; Lymphoma |
